Clinical Relevance of Failure to Achieve Early Molecular Response in Chronic Myeloid Leukemia in Chronic Phase

被引：0

作者：

Lee, Ji Yun ^{[1
]}

Lim, Sung Hee ^{[1
]}

Kim, Hae Su ^{[1
]}

Yoo, Kwai Han ^{[1
]}

Song, Haa-Na ^{[1
]}

Cho, Jinhyun ^{[1
]}

Park, Silvia ^{[1
]}

Kim, Seok Jin ^{[1
]}

Kim, Won Seog ^{[1
]}

Kim, Kihyun ^{[1
]}

Jang, Jun Ho ^{[1
]}

Jung, Chul Won ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Nivolumab to control molecular response in chronic myeloid leukemia
Rousselot, Philippe
Renard, Perrine
de Buyer, Ariane
Finet, Adeline
Spentchian, Marc
Saiag, Philippe
LEUKEMIA RESEARCH, 2018, 72 : 5 - 6
[32] Standardized definitions of molecular response in chronic myeloid leukemia
N C P Cross
H E White
M C Müller
G Saglio
A Hochhaus
Leukemia, 2012, 26 : 2172 - 2175
[33] Standardized definitions of molecular response in chronic myeloid leukemia
Cross, N. C. P.
White, H. E.
Mueller, M. C.
Saglio, G.
Hochhaus, A.
LEUKEMIA, 2012, 26 (10) : 2172 - 2175
[34] Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib
Lee, Sung-Eun
Choi, Soo Young
Kwak, Jae-Yong
Kim, Hawk
Kim, Jeong-A
Do, Young Rok
Kim, Hyeoung Joon
Park, Joon Seong
Chung, Joo Seop
Shin, Ho-Jin
Kim, Sung-Hyun
Kim, Dae-Young
Bunworasate, Udomsak
Choi, Chul Won
Cornejo Comia, Narcisa Sonia
Zang, Dae Young
Oh, Sukjoong
Jootar, Saengsuree
Reksodiputro, Ary Harryanto
Lee, Won Sik
Mun, Yeung-Chul
Kong, Jee Hyun
Caguioa, Priscilla B.
Park, Jinny
Jung, Chul Won
Kim, Dong-Wook
BLOOD, 2015, 126 (23)
[35] ELN 2013 response status criteria: Relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
Etienne, Gabriel
Dulucq, Stephanie
Lascaux, Axelle
Schmitt, Anna
Bidet, Audrey
Fort, Marie-Pierre
Lippert, Eric
Bureau, Caroline
Adiko, Didier
Hayette, Sandrine
Reiffers, Josy
Nicolini, Franck-Emmanuel
Mahon, Francois-Xavier
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (01) : 37 - 41
[36] Molecular response to imatinib in late chronic phase chronic myeloid leukemia. results of a phase II study by the Italian cooperative study group on chronic myeloid leukemia (ICSG on CML).
Rosti, G
Bassi, S
Elena, T
Testoni, N
Amabile, M
Martinelli, G
Giannini, B
De Vivo, A
Luatti, S
Bonifazi, F
Izzo, B
Salvatore, F
Gottardi, E
Cambrin, GR
Cilloni, D
Tiribelli, M
Pane, F
Russo, D
Saglio, G
Michele, B
BLOOD, 2003, 102 (11) : 907A - 907A
[37] Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
Millot, Frederic
Guilhot, Joelle
Baruchel, Andre
Petit, Arnaud
Bertrand, Yves
Mazingue, Francoise
Lutz, Patrick
Verite, Cecile
Berthou, Christian
Galambrun, Claire
Sirvent, Nicolas
Yakouben, Karima
Schmitt, Claudine
Gandemer, Virginie
Reguerre, Yves
Couillault, Gerard
Mechinaud, Francoise
Cayuela, Jean-Michel
BLOOD, 2014, 124 (15) : 2408 - 2410
[38] VERY EARLY MOLECULAR RESPONSE AT 1 MONTH CAN PREDICT 12-MONTH MAJOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH TKIS
Song, H. Y.
Choi, S. Y.
Lee, S. E.
Kim, S. H.
Yoo, H. L.
Lee, M. Y.
Hwang, H. J.
Kang, K. H.
Kee, K. M.
Kim, D. W.
HAEMATOLOGICA, 2016, 101 : 456 - 456
[39] EARLY SWITCH THERAPY APPROACH FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Shukhov, O.
Chelysheva, E.
Gusarova, G.
Abdullaev, A.
Sudarikov, A.
Obukhova, T.
Turkina, A.
HAEMATOLOGICA, 2014, 99 : 604 - 604
[40] Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response In Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia In Brazil.
Alves, Marcia Dias
Coombs, John
Ruiz, Jefferson
Valentim, Joice
Lemos, Marta M.
BLOOD, 2010, 116 (21) : 646 - 647

← 1 2 3 4 5 →